nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—Epirubicin—sarcoma	0.198	1	CrCtD
Doxorubicin—Anthracyclines—Epirubicin—sarcoma	0.0874	0.308	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Mitoxantrone—sarcoma	0.0846	0.298	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Etoposide—sarcoma	0.0664	0.234	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Epirubicin—sarcoma	0.0457	0.161	CiPCiCtD
Doxorubicin—Daunorubicin—Epirubicin—sarcoma	0.042	0.333	CrCrCtD
Doxorubicin—Idarubicin—Epirubicin—sarcoma	0.042	0.333	CrCrCtD
Doxorubicin—Valrubicin—Epirubicin—sarcoma	0.042	0.333	CrCrCtD
Doxorubicin—liver cancer—sarcoma	0.0307	0.178	CtDrD
Doxorubicin—uterine cancer—sarcoma	0.0263	0.152	CtDrD
Doxorubicin—bone cancer—sarcoma	0.0236	0.137	CtDrD
Doxorubicin—muscle cancer—sarcoma	0.0209	0.121	CtDrD
Doxorubicin—testicular cancer—sarcoma	0.0196	0.113	CtDrD
Doxorubicin—YWHAG—Epirubicin—sarcoma	0.0188	0.131	CbGbCtD
Doxorubicin—AURKA—Epirubicin—sarcoma	0.0188	0.131	CbGbCtD
Doxorubicin—DHCR7—Epirubicin—sarcoma	0.0188	0.131	CbGbCtD
Doxorubicin—kidney cancer—sarcoma	0.0175	0.101	CtDrD
Doxorubicin—peripheral nervous system neoplasm—sarcoma	0.0173	0.1	CtDrD
Doxorubicin—lung cancer—sarcoma	0.0169	0.0976	CtDrD
Doxorubicin—RALBP1—Vincristine—sarcoma	0.0127	0.0886	CbGbCtD
Doxorubicin—ABCC6—Dactinomycin—sarcoma	0.00991	0.0691	CbGbCtD
Doxorubicin—ABCC6—Etoposide—sarcoma	0.0056	0.039	CbGbCtD
Doxorubicin—TOP2A—Mitoxantrone—sarcoma	0.00472	0.0329	CbGbCtD
Doxorubicin—ABCC10—Vincristine—sarcoma	0.00466	0.0325	CbGbCtD
Doxorubicin—ABCC10—Etoposide—sarcoma	0.00427	0.0298	CbGbCtD
Doxorubicin—TOP2A—Epirubicin—sarcoma	0.00382	0.0266	CbGbCtD
Doxorubicin—CYP1B1—Mitoxantrone—sarcoma	0.00368	0.0257	CbGbCtD
Doxorubicin—TOP2A—Etoposide—sarcoma	0.00298	0.0208	CbGbCtD
Doxorubicin—ABCC3—Vincristine—sarcoma	0.00293	0.0205	CbGbCtD
Doxorubicin—ABCC1—Dactinomycin—sarcoma	0.00292	0.0204	CbGbCtD
Doxorubicin—CYP2B6—Thiotepa—sarcoma	0.00287	0.02	CbGbCtD
Doxorubicin—ABCC3—Etoposide—sarcoma	0.00269	0.0187	CbGbCtD
Doxorubicin—ABCC1—Mitoxantrone—sarcoma	0.00262	0.0182	CbGbCtD
Doxorubicin—ABCB11—Vincristine—sarcoma	0.00254	0.0177	CbGbCtD
Doxorubicin—ABCC1—Epirubicin—sarcoma	0.00212	0.0148	CbGbCtD
Doxorubicin—ABCG2—Dactinomycin—sarcoma	0.00196	0.0136	CbGbCtD
Doxorubicin—ABCC1—Vincristine—sarcoma	0.0018	0.0126	CbGbCtD
Doxorubicin—ABCG2—Mitoxantrone—sarcoma	0.00175	0.0122	CbGbCtD
Doxorubicin—ABCC1—Etoposide—sarcoma	0.00165	0.0115	CbGbCtD
Doxorubicin—ABCC2—Vincristine—sarcoma	0.00133	0.00929	CbGbCtD
Doxorubicin—ABCC2—Etoposide—sarcoma	0.00122	0.00852	CbGbCtD
Doxorubicin—ABCG2—Vincristine—sarcoma	0.00121	0.0084	CbGbCtD
Doxorubicin—ABCG2—Etoposide—sarcoma	0.0011	0.0077	CbGbCtD
Doxorubicin—CYP3A4—Thiotepa—sarcoma	0.00088	0.00614	CbGbCtD
Doxorubicin—ABCB1—Dactinomycin—sarcoma	0.000706	0.00492	CbGbCtD
Doxorubicin—ABCB1—Mitoxantrone—sarcoma	0.000632	0.0044	CbGbCtD
Doxorubicin—ABCC6—dermis—sarcoma	0.000625	0.0355	CbGeAlD
Doxorubicin—NOS3—pulmonary artery—sarcoma	0.00051	0.029	CbGeAlD
Doxorubicin—ABCB1—Vincristine—sarcoma	0.000435	0.00303	CbGbCtD
Doxorubicin—ABCB1—Etoposide—sarcoma	0.000398	0.00278	CbGbCtD
Doxorubicin—CYP3A4—Mitoxantrone—sarcoma	0.000378	0.00264	CbGbCtD
Doxorubicin—NOS3—umbilical vein—sarcoma	0.000337	0.0191	CbGeAlD
Doxorubicin—NOS3—hindlimb—sarcoma	0.000308	0.0175	CbGeAlD
Doxorubicin—NOS3—appendage—sarcoma	0.000264	0.015	CbGeAlD
Doxorubicin—CYP3A4—Vincristine—sarcoma	0.00026	0.00182	CbGbCtD
Doxorubicin—CYP3A4—Etoposide—sarcoma	0.000239	0.00166	CbGbCtD
Doxorubicin—AKR1A1—mammary gland—sarcoma	0.000223	0.0127	CbGeAlD
Doxorubicin—NOS1—endothelium—sarcoma	0.00021	0.0119	CbGeAlD
Doxorubicin—CBR3—myometrium—sarcoma	0.000205	0.0117	CbGeAlD
Doxorubicin—CBR3—embryo—sarcoma	0.000197	0.0112	CbGeAlD
Doxorubicin—AURKA—mammary gland—sarcoma	0.000189	0.0107	CbGeAlD
Doxorubicin—NOS2—tendon—sarcoma	0.000188	0.0107	CbGeAlD
Doxorubicin—CBR3—seminal vesicle—sarcoma	0.000185	0.0105	CbGeAlD
Doxorubicin—ABCB8—hematopoietic system—sarcoma	0.000183	0.0104	CbGeAlD
Doxorubicin—NOS3—endothelium—sarcoma	0.00016	0.00907	CbGeAlD
Doxorubicin—AKR1A1—myometrium—sarcoma	0.000158	0.009	CbGeAlD
Doxorubicin—DHCR7—mammary gland—sarcoma	0.000158	0.00897	CbGeAlD
Doxorubicin—SLC22A16—bone marrow—sarcoma	0.000151	0.00857	CbGeAlD
Doxorubicin—YWHAG—mammary gland—sarcoma	0.000145	0.00823	CbGeAlD
Doxorubicin—AKR1A1—seminal vesicle—sarcoma	0.000143	0.00813	CbGeAlD
Doxorubicin—AKR1A1—hematopoietic system—sarcoma	0.000136	0.00773	CbGeAlD
Doxorubicin—AURKA—myometrium—sarcoma	0.000134	0.00761	CbGeAlD
Doxorubicin—SLC22A16—testis—sarcoma	0.000129	0.00733	CbGeAlD
Doxorubicin—NOS3—mammary gland—sarcoma	0.000129	0.00731	CbGeAlD
Doxorubicin—NDUFS7—hematopoietic system—sarcoma	0.000124	0.00703	CbGeAlD
Doxorubicin—CBR1—mammary gland—sarcoma	0.000122	0.00694	CbGeAlD
Doxorubicin—AKR1A1—smooth muscle tissue—sarcoma	0.00012	0.00681	CbGeAlD
Doxorubicin—NDUFS2—myometrium—sarcoma	0.000119	0.00678	CbGeAlD
Doxorubicin—NDUFS7—connective tissue—sarcoma	0.000119	0.00676	CbGeAlD
Doxorubicin—AKR1A1—skin of body—sarcoma	0.000118	0.00672	CbGeAlD
Doxorubicin—NDUFS3—myometrium—sarcoma	0.000118	0.0067	CbGeAlD
Doxorubicin—CBR3—tendon—sarcoma	0.000117	0.00663	CbGeAlD
Doxorubicin—AURKA—hematopoietic system—sarcoma	0.000115	0.00653	CbGeAlD
Doxorubicin—ABCC6—Podofilox—Etoposide—sarcoma	0.000108	0.156	CbGdCrCtD
Doxorubicin—NDUFS2—seminal vesicle—sarcoma	0.000108	0.00613	CbGeAlD
Doxorubicin—NDUFS3—seminal vesicle—sarcoma	0.000106	0.00605	CbGeAlD
Doxorubicin—AKR1A1—cardiac atrium—sarcoma	0.000103	0.00587	CbGeAlD
Doxorubicin—NOS1—hematopoietic system—sarcoma	0.000103	0.00586	CbGeAlD
Doxorubicin—AKR1A1—uterus—sarcoma	0.000103	0.00584	CbGeAlD
Doxorubicin—YWHAG—myometrium—sarcoma	0.000103	0.00584	CbGeAlD
Doxorubicin—NDUFS2—hematopoietic system—sarcoma	0.000102	0.00582	CbGeAlD
Doxorubicin—NDUFS3—hematopoietic system—sarcoma	0.000101	0.00575	CbGeAlD
Doxorubicin—DHCR7—seminal vesicle—sarcoma	0.000101	0.00575	CbGeAlD
Doxorubicin—ABCB8—testis—sarcoma	0.0001	0.0057	CbGeAlD
Doxorubicin—NDUFS2—connective tissue—sarcoma	9.86e-05	0.00561	CbGeAlD
Doxorubicin—NQO1—mammary gland—sarcoma	9.78e-05	0.00556	CbGeAlD
Doxorubicin—CBR3—Teniposide—Etoposide—sarcoma	9.74e-05	0.14	CbGdCrCtD
Doxorubicin—NDUFS3—connective tissue—sarcoma	9.74e-05	0.00554	CbGeAlD
Doxorubicin—CBR3—testis—sarcoma	9.65e-05	0.00549	CbGeAlD
Doxorubicin—DHCR7—hematopoietic system—sarcoma	9.61e-05	0.00546	CbGeAlD
Doxorubicin—AKR1A1—lymphoid tissue—sarcoma	9.57e-05	0.00544	CbGeAlD
Doxorubicin—ABCB8—liver—sarcoma	9.48e-05	0.00539	CbGeAlD
Doxorubicin—AKR1C3—Podofilox—Etoposide—sarcoma	9.46e-05	0.136	CbGdCrCtD
Doxorubicin—NDUFS7—cardiac atrium—sarcoma	9.39e-05	0.00533	CbGeAlD
Doxorubicin—ABCC6—hematopoietic system—sarcoma	9.37e-05	0.00532	CbGeAlD
Doxorubicin—YWHAG—seminal vesicle—sarcoma	9.28e-05	0.00527	CbGeAlD
Doxorubicin—RALBP1—myometrium—sarcoma	9.28e-05	0.00527	CbGeAlD
Doxorubicin—NOS1—smooth muscle tissue—sarcoma	9.08e-05	0.00516	CbGeAlD
Doxorubicin—NDUFS2—smooth muscle tissue—sarcoma	9.02e-05	0.00513	CbGeAlD
Doxorubicin—ABCC6—connective tissue—sarcoma	9.02e-05	0.00513	CbGeAlD
Doxorubicin—AKR1A1—tendon—sarcoma	9e-05	0.00512	CbGeAlD
Doxorubicin—NDUFS3—smooth muscle tissue—sarcoma	8.91e-05	0.00506	CbGeAlD
Doxorubicin—NDUFS2—skin of body—sarcoma	8.9e-05	0.00506	CbGeAlD
Doxorubicin—YWHAG—hematopoietic system—sarcoma	8.82e-05	0.00501	CbGeAlD
Doxorubicin—NDUFS3—skin of body—sarcoma	8.8e-05	0.005	CbGeAlD
Doxorubicin—AKR1A1—bone marrow—sarcoma	8.72e-05	0.00496	CbGeAlD
Doxorubicin—AURKA—uterus—sarcoma	8.68e-05	0.00493	CbGeAlD
Doxorubicin—CBR1—myometrium—sarcoma	8.66e-05	0.00492	CbGeAlD
Doxorubicin—AKR1C3—myometrium—sarcoma	8.55e-05	0.00486	CbGeAlD
Doxorubicin—YWHAG—connective tissue—sarcoma	8.49e-05	0.00483	CbGeAlD
Doxorubicin—RALBP1—seminal vesicle—sarcoma	8.38e-05	0.00476	CbGeAlD
Doxorubicin—DHCR7—skin of body—sarcoma	8.36e-05	0.00475	CbGeAlD
Doxorubicin—NDUFS7—tendon—sarcoma	8.18e-05	0.00465	CbGeAlD
Doxorubicin—AURKA—lymphoid tissue—sarcoma	8.09e-05	0.0046	CbGeAlD
Doxorubicin—RALBP1—hematopoietic system—sarcoma	7.96e-05	0.00453	CbGeAlD
Doxorubicin—NDUFS7—bone marrow—sarcoma	7.92e-05	0.0045	CbGeAlD
Doxorubicin—NOS3—hematopoietic system—sarcoma	7.84e-05	0.00445	CbGeAlD
Doxorubicin—CBR1—seminal vesicle—sarcoma	7.82e-05	0.00445	CbGeAlD
Doxorubicin—POR—myometrium—sarcoma	7.81e-05	0.00444	CbGeAlD
Doxorubicin—NDUFS2—cardiac atrium—sarcoma	7.78e-05	0.00442	CbGeAlD
Doxorubicin—YWHAG—smooth muscle tissue—sarcoma	7.77e-05	0.00442	CbGeAlD
Doxorubicin—NDUFS2—uterus—sarcoma	7.74e-05	0.0044	CbGeAlD
Doxorubicin—AKR1C3—seminal vesicle—sarcoma	7.73e-05	0.00439	CbGeAlD
Doxorubicin—NDUFS3—cardiac atrium—sarcoma	7.68e-05	0.00437	CbGeAlD
Doxorubicin—NDUFS3—uterus—sarcoma	7.64e-05	0.00434	CbGeAlD
Doxorubicin—AURKA—tendon—sarcoma	7.61e-05	0.00432	CbGeAlD
Doxorubicin—NOS3—connective tissue—sarcoma	7.54e-05	0.00429	CbGeAlD
Doxorubicin—AKR1A1—testis—sarcoma	7.45e-05	0.00424	CbGeAlD
Doxorubicin—AURKA—bone marrow—sarcoma	7.37e-05	0.00419	CbGeAlD
Doxorubicin—DHCR7—cardiac atrium—sarcoma	7.3e-05	0.00415	CbGeAlD
Doxorubicin—TOP2A—myometrium—sarcoma	7.28e-05	0.00414	CbGeAlD
Doxorubicin—ABCB8—lymph node—sarcoma	7.27e-05	0.00413	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—sarcoma	7.21e-05	0.0041	CbGeAlD
Doxorubicin—NDUFS3—lymphoid tissue—sarcoma	7.12e-05	0.00405	CbGeAlD
Doxorubicin—POR—seminal vesicle—sarcoma	7.06e-05	0.00401	CbGeAlD
Doxorubicin—AKR1A1—liver—sarcoma	7.05e-05	0.00401	CbGeAlD
Doxorubicin—RALBP1—smooth muscle tissue—sarcoma	7.02e-05	0.00399	CbGeAlD
Doxorubicin—CBR3—lymph node—sarcoma	7e-05	0.00398	CbGeAlD
Doxorubicin—NQO1—myometrium—sarcoma	6.94e-05	0.00394	CbGeAlD
Doxorubicin—NOS3—smooth muscle tissue—sarcoma	6.9e-05	0.00392	CbGeAlD
Doxorubicin—CYP1B1—mammary gland—sarcoma	6.87e-05	0.0039	CbGeAlD
Doxorubicin—NOS1—tendon—sarcoma	6.82e-05	0.00388	CbGeAlD
Doxorubicin—NDUFS2—tendon—sarcoma	6.78e-05	0.00385	CbGeAlD
Doxorubicin—NDUFS7—testis—sarcoma	6.77e-05	0.00385	CbGeAlD
Doxorubicin—DHCR7—lymphoid tissue—sarcoma	6.77e-05	0.00385	CbGeAlD
Doxorubicin—YWHAG—cardiac atrium—sarcoma	6.7e-05	0.00381	CbGeAlD
Doxorubicin—NDUFS3—tendon—sarcoma	6.7e-05	0.00381	CbGeAlD
Doxorubicin—YWHAG—uterus—sarcoma	6.66e-05	0.00379	CbGeAlD
Doxorubicin—NDUFS2—bone marrow—sarcoma	6.57e-05	0.00373	CbGeAlD
Doxorubicin—AKR1C3—Vinblastine—Vincristine—sarcoma	6.51e-05	0.0936	CbGdCrCtD
Doxorubicin—NDUFS3—bone marrow—sarcoma	6.49e-05	0.00369	CbGeAlD
Doxorubicin—AKR1C3—smooth muscle tissue—sarcoma	6.47e-05	0.00368	CbGeAlD
Doxorubicin—CBR1—skin of body—sarcoma	6.46e-05	0.00367	CbGeAlD
Doxorubicin—NDUFS7—liver—sarcoma	6.4e-05	0.00364	CbGeAlD
Doxorubicin—AURKA—testis—sarcoma	6.3e-05	0.00358	CbGeAlD
Doxorubicin—NQO1—seminal vesicle—sarcoma	6.27e-05	0.00356	CbGeAlD
Doxorubicin—YWHAG—lymphoid tissue—sarcoma	6.21e-05	0.00353	CbGeAlD
Doxorubicin—ABCC10—myometrium—sarcoma	6.2e-05	0.00352	CbGeAlD
Doxorubicin—DHCR7—bone marrow—sarcoma	6.16e-05	0.0035	CbGeAlD
Doxorubicin—RALBP1—cardiac atrium—sarcoma	6.05e-05	0.00344	CbGeAlD
Doxorubicin—RALBP1—uterus—sarcoma	6.02e-05	0.00342	CbGeAlD
Doxorubicin—NQO1—hematopoietic system—sarcoma	5.96e-05	0.00339	CbGeAlD
Doxorubicin—AURKA—liver—sarcoma	5.95e-05	0.00338	CbGeAlD
Doxorubicin—YWHAG—tendon—sarcoma	5.84e-05	0.00332	CbGeAlD
Doxorubicin—NQO1—connective tissue—sarcoma	5.74e-05	0.00326	CbGeAlD
Doxorubicin—YWHAG—bone marrow—sarcoma	5.65e-05	0.00321	CbGeAlD
Doxorubicin—NOS1—testis—sarcoma	5.65e-05	0.00321	CbGeAlD
Doxorubicin—CBR1—cardiac atrium—sarcoma	5.65e-05	0.00321	CbGeAlD
Doxorubicin—CBR1—uterus—sarcoma	5.62e-05	0.00319	CbGeAlD
Doxorubicin—NDUFS2—testis—sarcoma	5.61e-05	0.00319	CbGeAlD
Doxorubicin—ABCC10—seminal vesicle—sarcoma	5.6e-05	0.00318	CbGeAlD
Doxorubicin—AKR1C3—cardiac atrium—sarcoma	5.58e-05	0.00317	CbGeAlD
Doxorubicin—AKR1C3—uterus—sarcoma	5.55e-05	0.00315	CbGeAlD
Doxorubicin—NDUFS3—testis—sarcoma	5.54e-05	0.00315	CbGeAlD
Doxorubicin—NOS3—lymphoid tissue—sarcoma	5.52e-05	0.00314	CbGeAlD
Doxorubicin—AKR1A1—lymph node—sarcoma	5.4e-05	0.00307	CbGeAlD
Doxorubicin—ABCC3—hematopoietic system—sarcoma	5.35e-05	0.00304	CbGeAlD
Doxorubicin—ABCC10—hematopoietic system—sarcoma	5.32e-05	0.00302	CbGeAlD
Doxorubicin—NDUFS2—liver—sarcoma	5.31e-05	0.00302	CbGeAlD
Doxorubicin—RALBP1—tendon—sarcoma	5.27e-05	0.003	CbGeAlD
Doxorubicin—DHCR7—testis—sarcoma	5.27e-05	0.00299	CbGeAlD
Doxorubicin—NQO1—smooth muscle tissue—sarcoma	5.25e-05	0.00298	CbGeAlD
Doxorubicin—NDUFS3—liver—sarcoma	5.24e-05	0.00298	CbGeAlD
Doxorubicin—CBR1—lymphoid tissue—sarcoma	5.24e-05	0.00298	CbGeAlD
Doxorubicin—NOS3—tendon—sarcoma	5.19e-05	0.00295	CbGeAlD
Doxorubicin—NQO1—skin of body—sarcoma	5.18e-05	0.00294	CbGeAlD
Doxorubicin—AURKA—Teniposide—Etoposide—sarcoma	5.13e-05	0.0738	CbGdCrCtD
Doxorubicin—RALBP1—bone marrow—sarcoma	5.11e-05	0.0029	CbGeAlD
Doxorubicin—POR—cardiac atrium—sarcoma	5.09e-05	0.00289	CbGeAlD
Doxorubicin—CBR3—Daunorubicin—Epirubicin—sarcoma	5.08e-05	0.073	CbGdCrCtD
Doxorubicin—CBR3—Idarubicin—Epirubicin—sarcoma	5.08e-05	0.073	CbGdCrCtD
Doxorubicin—DHCR7—liver—sarcoma	4.98e-05	0.00283	CbGeAlD
Doxorubicin—CBR1—tendon—sarcoma	4.92e-05	0.0028	CbGeAlD
Doxorubicin—NDUFS7—lymph node—sarcoma	4.91e-05	0.00279	CbGeAlD
Doxorubicin—AKR1C3—tendon—sarcoma	4.86e-05	0.00276	CbGeAlD
Doxorubicin—ABCC6—liver—sarcoma	4.85e-05	0.00276	CbGeAlD
Doxorubicin—YWHAG—testis—sarcoma	4.83e-05	0.00275	CbGeAlD
Doxorubicin—CBR1—bone marrow—sarcoma	4.77e-05	0.00271	CbGeAlD
Doxorubicin—TOP2A—uterus—sarcoma	4.72e-05	0.00268	CbGeAlD
Doxorubicin—AKR1C3—bone marrow—sarcoma	4.71e-05	0.00268	CbGeAlD
Doxorubicin—ABCB11—testis—sarcoma	4.6e-05	0.00262	CbGeAlD
Doxorubicin—YWHAG—liver—sarcoma	4.57e-05	0.0026	CbGeAlD
Doxorubicin—AURKA—lymph node—sarcoma	4.56e-05	0.00259	CbGeAlD
Doxorubicin—NQO1—uterus—sarcoma	4.5e-05	0.00256	CbGeAlD
Doxorubicin—XDH—liver—sarcoma	4.46e-05	0.00253	CbGeAlD
Doxorubicin—POR—tendon—sarcoma	4.44e-05	0.00252	CbGeAlD
Doxorubicin—ABCC1—myometrium—sarcoma	4.38e-05	0.00249	CbGeAlD
Doxorubicin—RALBP1—testis—sarcoma	4.36e-05	0.00248	CbGeAlD
Doxorubicin—ABCB11—liver—sarcoma	4.35e-05	0.00247	CbGeAlD
Doxorubicin—POR—bone marrow—sarcoma	4.3e-05	0.00244	CbGeAlD
Doxorubicin—NOS3—testis—sarcoma	4.29e-05	0.00244	CbGeAlD
Doxorubicin—CYP1B1—hematopoietic system—sarcoma	4.18e-05	0.00238	CbGeAlD
Doxorubicin—TOP2A—tendon—sarcoma	4.14e-05	0.00235	CbGeAlD
Doxorubicin—RALBP1—liver—sarcoma	4.13e-05	0.00235	CbGeAlD
Doxorubicin—CBR1—testis—sarcoma	4.07e-05	0.00232	CbGeAlD
Doxorubicin—NDUFS2—lymph node—sarcoma	4.07e-05	0.00231	CbGeAlD
Doxorubicin—NOS3—liver—sarcoma	4.06e-05	0.00231	CbGeAlD
Doxorubicin—ABCC10—cardiac atrium—sarcoma	4.04e-05	0.0023	CbGeAlD
Doxorubicin—CYP1B1—connective tissue—sarcoma	4.03e-05	0.00229	CbGeAlD
Doxorubicin—AKR1C3—testis—sarcoma	4.02e-05	0.00229	CbGeAlD
Doxorubicin—ABCC10—uterus—sarcoma	4.02e-05	0.00228	CbGeAlD
Doxorubicin—NDUFS3—lymph node—sarcoma	4.02e-05	0.00228	CbGeAlD
Doxorubicin—TOP2A—bone marrow—sarcoma	4.01e-05	0.00228	CbGeAlD
Doxorubicin—ABCC1—seminal vesicle—sarcoma	3.96e-05	0.00225	CbGeAlD
Doxorubicin—NQO1—tendon—sarcoma	3.94e-05	0.00224	CbGeAlD
Doxorubicin—CBR1—liver—sarcoma	3.85e-05	0.00219	CbGeAlD
Doxorubicin—DHCR7—lymph node—sarcoma	3.82e-05	0.00217	CbGeAlD
Doxorubicin—AKR1C3—liver—sarcoma	3.8e-05	0.00216	CbGeAlD
Doxorubicin—ABCC10—lymphoid tissue—sarcoma	3.75e-05	0.00213	CbGeAlD
Doxorubicin—CYP1B1—smooth muscle tissue—sarcoma	3.69e-05	0.00209	CbGeAlD
Doxorubicin—POR—testis—sarcoma	3.67e-05	0.00209	CbGeAlD
Doxorubicin—CYP1B1—skin of body—sarcoma	3.64e-05	0.00207	CbGeAlD
Doxorubicin—ABCG2—myometrium—sarcoma	3.63e-05	0.00206	CbGeAlD
Doxorubicin—ABCC10—tendon—sarcoma	3.52e-05	0.002	CbGeAlD
Doxorubicin—YWHAG—lymph node—sarcoma	3.5e-05	0.00199	CbGeAlD
Doxorubicin—POR—liver—sarcoma	3.47e-05	0.00197	CbGeAlD
Doxorubicin—TOP2A—testis—sarcoma	3.43e-05	0.00195	CbGeAlD
Doxorubicin—ABCC10—bone marrow—sarcoma	3.41e-05	0.00194	CbGeAlD
Doxorubicin—ABCG2—seminal vesicle—sarcoma	3.28e-05	0.00186	CbGeAlD
Doxorubicin—NQO1—testis—sarcoma	3.26e-05	0.00186	CbGeAlD
Doxorubicin—RALBP1—lymph node—sarcoma	3.16e-05	0.0018	CbGeAlD
Doxorubicin—CYP1B1—uterus—sarcoma	3.16e-05	0.0018	CbGeAlD
Doxorubicin—NOS3—lymph node—sarcoma	3.11e-05	0.00177	CbGeAlD
Doxorubicin—TOP2A—Vindesine—Vincristine—sarcoma	3.11e-05	0.0447	CbGdCrCtD
Doxorubicin—NQO1—liver—sarcoma	3.09e-05	0.00175	CbGeAlD
Doxorubicin—CBR1—lymph node—sarcoma	2.95e-05	0.00168	CbGeAlD
Doxorubicin—CYP1B1—lymphoid tissue—sarcoma	2.95e-05	0.00167	CbGeAlD
Doxorubicin—ABCC3—testis—sarcoma	2.93e-05	0.00167	CbGeAlD
Doxorubicin—AKR1C3—lymph node—sarcoma	2.92e-05	0.00166	CbGeAlD
Doxorubicin—ABCC10—testis—sarcoma	2.92e-05	0.00166	CbGeAlD
Doxorubicin—CYP2B6—hematopoietic system—sarcoma	2.87e-05	0.00163	CbGeAlD
Doxorubicin—ABCC1—cardiac atrium—sarcoma	2.86e-05	0.00162	CbGeAlD
Doxorubicin—ABCC1—uterus—sarcoma	2.84e-05	0.00162	CbGeAlD
Doxorubicin—ABCC2—tendon—sarcoma	2.83e-05	0.00161	CbGeAlD
Doxorubicin—ABCC3—liver—sarcoma	2.77e-05	0.00157	CbGeAlD
Doxorubicin—CYP1B1—tendon—sarcoma	2.77e-05	0.00157	CbGeAlD
Doxorubicin—ABCC10—liver—sarcoma	2.76e-05	0.00157	CbGeAlD
Doxorubicin—AURKA—Idarubicin—Epirubicin—sarcoma	2.68e-05	0.0385	CbGdCrCtD
Doxorubicin—AURKA—Daunorubicin—Epirubicin—sarcoma	2.68e-05	0.0385	CbGdCrCtD
Doxorubicin—POR—lymph node—sarcoma	2.66e-05	0.00151	CbGeAlD
Doxorubicin—CYP2B6—skin of body—sarcoma	2.5e-05	0.00142	CbGeAlD
Doxorubicin—ABCC1—tendon—sarcoma	2.49e-05	0.00142	CbGeAlD
Doxorubicin—TOP2A—lymph node—sarcoma	2.48e-05	0.00141	CbGeAlD
Doxorubicin—NQO1—lymph node—sarcoma	2.37e-05	0.00135	CbGeAlD
Doxorubicin—ABCG2—uterus—sarcoma	2.35e-05	0.00134	CbGeAlD
Doxorubicin—ABCC2—testis—sarcoma	2.34e-05	0.00133	CbGeAlD
Doxorubicin—CYP1B1—testis—sarcoma	2.29e-05	0.0013	CbGeAlD
Doxorubicin—ABCC2—liver—sarcoma	2.21e-05	0.00126	CbGeAlD
Doxorubicin—CYP3A4—hematopoietic system—sarcoma	2.17e-05	0.00123	CbGeAlD
Doxorubicin—CYP1B1—liver—sarcoma	2.17e-05	0.00123	CbGeAlD
Doxorubicin—CYP2D6—hematopoietic system—sarcoma	2.14e-05	0.00121	CbGeAlD
Doxorubicin—ABCC3—lymph node—sarcoma	2.12e-05	0.00121	CbGeAlD
Doxorubicin—ABCC10—lymph node—sarcoma	2.11e-05	0.0012	CbGeAlD
Doxorubicin—ABCC1—testis—sarcoma	2.06e-05	0.00117	CbGeAlD
Doxorubicin—CYP2B6—lymphoid tissue—sarcoma	2.02e-05	0.00115	CbGeAlD
Doxorubicin—ABCG2—bone marrow—sarcoma	2e-05	0.00114	CbGeAlD
Doxorubicin—TOP2A—Vinorelbine—Vincristine—sarcoma	1.96e-05	0.0282	CbGdCrCtD
Doxorubicin—TOP2A—Podofilox—Etoposide—sarcoma	1.96e-05	0.0282	CbGdCrCtD
Doxorubicin—TOP2A—Teniposide—Etoposide—sarcoma	1.96e-05	0.0282	CbGdCrCtD
Doxorubicin—ABCC1—liver—sarcoma	1.95e-05	0.00111	CbGeAlD
Doxorubicin—ABCB1—myometrium—sarcoma	1.79e-05	0.00102	CbGeAlD
Doxorubicin—ABCB1—embryo—sarcoma	1.72e-05	0.000978	CbGeAlD
Doxorubicin—ABCG2—testis—sarcoma	1.71e-05	0.00097	CbGeAlD
Doxorubicin—ABCC2—lymph node—sarcoma	1.7e-05	0.000965	CbGeAlD
Doxorubicin—CYP1B1—lymph node—sarcoma	1.66e-05	0.000945	CbGeAlD
Doxorubicin—ABCB1—seminal vesicle—sarcoma	1.62e-05	0.000919	CbGeAlD
Doxorubicin—ABCG2—liver—sarcoma	1.61e-05	0.000918	CbGeAlD
Doxorubicin—CYP2B6—testis—sarcoma	1.58e-05	0.000895	CbGeAlD
Doxorubicin—ABCB1—hematopoietic system—sarcoma	1.54e-05	0.000873	CbGeAlD
Doxorubicin—ABCC1—lymph node—sarcoma	1.49e-05	0.00085	CbGeAlD
Doxorubicin—CYP2B6—liver—sarcoma	1.49e-05	0.000846	CbGeAlD
Doxorubicin—TOP2A—Vinblastine—Vincristine—sarcoma	1.35e-05	0.0194	CbGdCrCtD
Doxorubicin—ABCG2—lymph node—sarcoma	1.24e-05	0.000703	CbGeAlD
Doxorubicin—CYP2D6—testis—sarcoma	1.17e-05	0.000665	CbGeAlD
Doxorubicin—ABCB1—uterus—sarcoma	1.16e-05	0.00066	CbGeAlD
Doxorubicin—CYP3A4—liver—sarcoma	1.12e-05	0.000639	CbGeAlD
Doxorubicin—CYP2D6—liver—sarcoma	1.11e-05	0.000629	CbGeAlD
Doxorubicin—ABCB1—lymphoid tissue—sarcoma	1.08e-05	0.000615	CbGeAlD
Doxorubicin—TOP2A—Idarubicin—Epirubicin—sarcoma	1.02e-05	0.0147	CbGdCrCtD
Doxorubicin—TOP2A—Daunorubicin—Epirubicin—sarcoma	1.02e-05	0.0147	CbGdCrCtD
Doxorubicin—Musculoskeletal discomfort—Vincristine—sarcoma	9.85e-06	0.000255	CcSEcCtD
Doxorubicin—ABCB1—bone marrow—sarcoma	9.85e-06	0.00056	CbGeAlD
Doxorubicin—Hypotension—Mitoxantrone—sarcoma	9.84e-06	0.000255	CcSEcCtD
Doxorubicin—Migraine—Epirubicin—sarcoma	9.84e-06	0.000255	CcSEcCtD
Doxorubicin—Affect lability—Epirubicin—sarcoma	9.84e-06	0.000255	CcSEcCtD
Doxorubicin—Insomnia—Vincristine—sarcoma	9.78e-06	0.000253	CcSEcCtD
Doxorubicin—Paraesthesia—Vincristine—sarcoma	9.71e-06	0.000251	CcSEcCtD
Doxorubicin—Urticaria—Thiotepa—sarcoma	9.69e-06	0.000251	CcSEcCtD
Doxorubicin—Malaise—Etoposide—sarcoma	9.68e-06	0.000251	CcSEcCtD
Doxorubicin—Face oedema—Epirubicin—sarcoma	9.65e-06	0.00025	CcSEcCtD
Doxorubicin—Vertigo—Etoposide—sarcoma	9.65e-06	0.00025	CcSEcCtD
Doxorubicin—Abdominal pain—Thiotepa—sarcoma	9.64e-06	0.00025	CcSEcCtD
Doxorubicin—Body temperature increased—Thiotepa—sarcoma	9.64e-06	0.00025	CcSEcCtD
Doxorubicin—Leukopenia—Etoposide—sarcoma	9.61e-06	0.000249	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	9.6e-06	0.000248	CcSEcCtD
Doxorubicin—Body temperature increased—Dactinomycin—sarcoma	9.57e-06	0.000248	CcSEcCtD
Doxorubicin—Abdominal pain—Dactinomycin—sarcoma	9.57e-06	0.000248	CcSEcCtD
Doxorubicin—Cardiac arrest—Epirubicin—sarcoma	9.5e-06	0.000246	CcSEcCtD
Doxorubicin—Mood swings—Epirubicin—sarcoma	9.47e-06	0.000245	CcSEcCtD
Doxorubicin—Paraesthesia—Mitoxantrone—sarcoma	9.46e-06	0.000245	CcSEcCtD
Doxorubicin—Loss of consciousness—Etoposide—sarcoma	9.44e-06	0.000244	CcSEcCtD
Doxorubicin—Decreased appetite—Vincristine—sarcoma	9.4e-06	0.000243	CcSEcCtD
Doxorubicin—Ataxia—Epirubicin—sarcoma	9.4e-06	0.000243	CcSEcCtD
Doxorubicin—Dyspnoea—Mitoxantrone—sarcoma	9.39e-06	0.000243	CcSEcCtD
Doxorubicin—Cough—Etoposide—sarcoma	9.37e-06	0.000242	CcSEcCtD
Doxorubicin—Somnolence—Mitoxantrone—sarcoma	9.36e-06	0.000242	CcSEcCtD
Doxorubicin—Blood creatinine increased—Epirubicin—sarcoma	9.36e-06	0.000242	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Vincristine—sarcoma	9.34e-06	0.000242	CcSEcCtD
Doxorubicin—Fatigue—Vincristine—sarcoma	9.33e-06	0.000241	CcSEcCtD
Doxorubicin—Convulsion—Etoposide—sarcoma	9.3e-06	0.000241	CcSEcCtD
Doxorubicin—Dehydration—Epirubicin—sarcoma	9.29e-06	0.000241	CcSEcCtD
Doxorubicin—Dyspepsia—Mitoxantrone—sarcoma	9.27e-06	0.00024	CcSEcCtD
Doxorubicin—Hypertension—Etoposide—sarcoma	9.27e-06	0.00024	CcSEcCtD
Doxorubicin—Constipation—Vincristine—sarcoma	9.25e-06	0.000239	CcSEcCtD
Doxorubicin—Pain—Vincristine—sarcoma	9.25e-06	0.000239	CcSEcCtD
Doxorubicin—Liver function test abnormal—Epirubicin—sarcoma	9.23e-06	0.000239	CcSEcCtD
Doxorubicin—Dry skin—Epirubicin—sarcoma	9.16e-06	0.000237	CcSEcCtD
Doxorubicin—Decreased appetite—Mitoxantrone—sarcoma	9.16e-06	0.000237	CcSEcCtD
Doxorubicin—Chest pain—Etoposide—sarcoma	9.14e-06	0.000237	CcSEcCtD
Doxorubicin—Orthostatic hypotension—Epirubicin—sarcoma	9.13e-06	0.000236	CcSEcCtD
Doxorubicin—Abdominal pain upper—Epirubicin—sarcoma	9.13e-06	0.000236	CcSEcCtD
Doxorubicin—Hypokalaemia—Epirubicin—sarcoma	9.09e-06	0.000235	CcSEcCtD
Doxorubicin—Fatigue—Mitoxantrone—sarcoma	9.08e-06	0.000235	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	9.08e-06	0.000235	CcSEcCtD
Doxorubicin—Discomfort—Etoposide—sarcoma	9.03e-06	0.000234	CcSEcCtD
Doxorubicin—Breast disorder—Epirubicin—sarcoma	9.03e-06	0.000234	CcSEcCtD
Doxorubicin—Pain—Mitoxantrone—sarcoma	9.01e-06	0.000233	CcSEcCtD
Doxorubicin—Constipation—Mitoxantrone—sarcoma	9.01e-06	0.000233	CcSEcCtD
Doxorubicin—Aspartate aminotransferase increased—Epirubicin—sarcoma	9e-06	0.000233	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Epirubicin—sarcoma	9e-06	0.000233	CcSEcCtD
Doxorubicin—Hypersensitivity—Thiotepa—sarcoma	8.99e-06	0.000233	CcSEcCtD
Doxorubicin—Nasopharyngitis—Epirubicin—sarcoma	8.94e-06	0.000231	CcSEcCtD
Doxorubicin—Hypersensitivity—Dactinomycin—sarcoma	8.92e-06	0.000231	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Vincristine—sarcoma	8.84e-06	0.000229	CcSEcCtD
Doxorubicin—Gastritis—Epirubicin—sarcoma	8.84e-06	0.000229	CcSEcCtD
Doxorubicin—Confusional state—Etoposide—sarcoma	8.83e-06	0.000229	CcSEcCtD
Doxorubicin—Alanine aminotransferase increased—Epirubicin—sarcoma	8.81e-06	0.000228	CcSEcCtD
Doxorubicin—Muscular weakness—Epirubicin—sarcoma	8.81e-06	0.000228	CcSEcCtD
Doxorubicin—Anaphylactic shock—Etoposide—sarcoma	8.76e-06	0.000227	CcSEcCtD
Doxorubicin—Asthenia—Thiotepa—sarcoma	8.75e-06	0.000227	CcSEcCtD
Doxorubicin—Infection—Etoposide—sarcoma	8.7e-06	0.000225	CcSEcCtD
Doxorubicin—Abdominal distension—Epirubicin—sarcoma	8.69e-06	0.000225	CcSEcCtD
Doxorubicin—Asthenia—Dactinomycin—sarcoma	8.69e-06	0.000225	CcSEcCtD
Doxorubicin—Feeling abnormal—Mitoxantrone—sarcoma	8.68e-06	0.000225	CcSEcCtD
Doxorubicin—Asthma—Epirubicin—sarcoma	8.64e-06	0.000224	CcSEcCtD
Doxorubicin—Dysphagia—Epirubicin—sarcoma	8.64e-06	0.000224	CcSEcCtD
Doxorubicin—Influenza—Epirubicin—sarcoma	8.64e-06	0.000224	CcSEcCtD
Doxorubicin—Pruritus—Thiotepa—sarcoma	8.63e-06	0.000223	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Mitoxantrone—sarcoma	8.61e-06	0.000223	CcSEcCtD
Doxorubicin—Thrombocytopenia—Etoposide—sarcoma	8.58e-06	0.000222	CcSEcCtD
Doxorubicin—Tachycardia—Etoposide—sarcoma	8.55e-06	0.000221	CcSEcCtD
Doxorubicin—Eosinophilia—Epirubicin—sarcoma	8.55e-06	0.000221	CcSEcCtD
Doxorubicin—Abdominal pain—Vincristine—sarcoma	8.55e-06	0.000221	CcSEcCtD
Doxorubicin—Body temperature increased—Vincristine—sarcoma	8.55e-06	0.000221	CcSEcCtD
Doxorubicin—Skin disorder—Etoposide—sarcoma	8.51e-06	0.00022	CcSEcCtD
Doxorubicin—Hyperhidrosis—Etoposide—sarcoma	8.47e-06	0.000219	CcSEcCtD
Doxorubicin—Pancreatitis—Epirubicin—sarcoma	8.47e-06	0.000219	CcSEcCtD
Doxorubicin—ABCB1—testis—sarcoma	8.42e-06	0.000479	CbGeAlD
Doxorubicin—Angina pectoris—Epirubicin—sarcoma	8.41e-06	0.000218	CcSEcCtD
Doxorubicin—Urticaria—Mitoxantrone—sarcoma	8.37e-06	0.000217	CcSEcCtD
Doxorubicin—Anorexia—Etoposide—sarcoma	8.35e-06	0.000216	CcSEcCtD
Doxorubicin—Diarrhoea—Thiotepa—sarcoma	8.35e-06	0.000216	CcSEcCtD
Doxorubicin—Body temperature increased—Mitoxantrone—sarcoma	8.33e-06	0.000216	CcSEcCtD
Doxorubicin—Abdominal pain—Mitoxantrone—sarcoma	8.33e-06	0.000216	CcSEcCtD
Doxorubicin—Bronchitis—Epirubicin—sarcoma	8.31e-06	0.000215	CcSEcCtD
Doxorubicin—Diarrhoea—Dactinomycin—sarcoma	8.28e-06	0.000214	CcSEcCtD
Doxorubicin—Pancytopenia—Epirubicin—sarcoma	8.2e-06	0.000212	CcSEcCtD
Doxorubicin—Hypotension—Etoposide—sarcoma	8.19e-06	0.000212	CcSEcCtD
Doxorubicin—Dysuria—Epirubicin—sarcoma	8.08e-06	0.000209	CcSEcCtD
Doxorubicin—Neutropenia—Epirubicin—sarcoma	8.08e-06	0.000209	CcSEcCtD
Doxorubicin—Dizziness—Thiotepa—sarcoma	8.07e-06	0.000209	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Epirubicin—sarcoma	8.03e-06	0.000208	CcSEcCtD
Doxorubicin—Pollakiuria—Epirubicin—sarcoma	7.98e-06	0.000207	CcSEcCtD
Doxorubicin—Hypersensitivity—Vincristine—sarcoma	7.97e-06	0.000206	CcSEcCtD
Doxorubicin—ABCB1—liver—sarcoma	7.96e-06	0.000452	CbGeAlD
Doxorubicin—Photosensitivity reaction—Epirubicin—sarcoma	7.88e-06	0.000204	CcSEcCtD
Doxorubicin—Paraesthesia—Etoposide—sarcoma	7.87e-06	0.000204	CcSEcCtD
Doxorubicin—Weight increased—Epirubicin—sarcoma	7.86e-06	0.000203	CcSEcCtD
Doxorubicin—Weight decreased—Epirubicin—sarcoma	7.81e-06	0.000202	CcSEcCtD
Doxorubicin—Dyspnoea—Etoposide—sarcoma	7.81e-06	0.000202	CcSEcCtD
Doxorubicin—Hyperglycaemia—Epirubicin—sarcoma	7.79e-06	0.000202	CcSEcCtD
Doxorubicin—Somnolence—Etoposide—sarcoma	7.79e-06	0.000202	CcSEcCtD
Doxorubicin—Hypersensitivity—Mitoxantrone—sarcoma	7.76e-06	0.000201	CcSEcCtD
Doxorubicin—Asthenia—Vincristine—sarcoma	7.76e-06	0.000201	CcSEcCtD
Doxorubicin—Vomiting—Thiotepa—sarcoma	7.76e-06	0.000201	CcSEcCtD
Doxorubicin—Pneumonia—Epirubicin—sarcoma	7.75e-06	0.0002	CcSEcCtD
Doxorubicin—Infestation—Epirubicin—sarcoma	7.7e-06	0.000199	CcSEcCtD
Doxorubicin—Infestation NOS—Epirubicin—sarcoma	7.7e-06	0.000199	CcSEcCtD
Doxorubicin—Drowsiness—Epirubicin—sarcoma	7.7e-06	0.000199	CcSEcCtD
Doxorubicin—Vomiting—Dactinomycin—sarcoma	7.7e-06	0.000199	CcSEcCtD
Doxorubicin—Rash—Thiotepa—sarcoma	7.69e-06	0.000199	CcSEcCtD
Doxorubicin—Dermatitis—Thiotepa—sarcoma	7.68e-06	0.000199	CcSEcCtD
Doxorubicin—Headache—Thiotepa—sarcoma	7.64e-06	0.000198	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Epirubicin—sarcoma	7.63e-06	0.000198	CcSEcCtD
Doxorubicin—Rash—Dactinomycin—sarcoma	7.63e-06	0.000198	CcSEcCtD
Doxorubicin—Decreased appetite—Etoposide—sarcoma	7.62e-06	0.000197	CcSEcCtD
Doxorubicin—Renal failure—Epirubicin—sarcoma	7.57e-06	0.000196	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Etoposide—sarcoma	7.56e-06	0.000196	CcSEcCtD
Doxorubicin—Asthenia—Mitoxantrone—sarcoma	7.56e-06	0.000196	CcSEcCtD
Doxorubicin—Fatigue—Etoposide—sarcoma	7.55e-06	0.000196	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Epirubicin—sarcoma	7.55e-06	0.000195	CcSEcCtD
Doxorubicin—Stomatitis—Epirubicin—sarcoma	7.51e-06	0.000194	CcSEcCtD
Doxorubicin—Jaundice—Epirubicin—sarcoma	7.51e-06	0.000194	CcSEcCtD
Doxorubicin—Pain—Etoposide—sarcoma	7.49e-06	0.000194	CcSEcCtD
Doxorubicin—Constipation—Etoposide—sarcoma	7.49e-06	0.000194	CcSEcCtD
Doxorubicin—Urinary tract infection—Epirubicin—sarcoma	7.49e-06	0.000194	CcSEcCtD
Doxorubicin—Conjunctivitis—Epirubicin—sarcoma	7.49e-06	0.000194	CcSEcCtD
Doxorubicin—Diarrhoea—Vincristine—sarcoma	7.4e-06	0.000192	CcSEcCtD
Doxorubicin—Sweating—Epirubicin—sarcoma	7.38e-06	0.000191	CcSEcCtD
Doxorubicin—Haematuria—Epirubicin—sarcoma	7.34e-06	0.00019	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Epirubicin—sarcoma	7.28e-06	0.000189	CcSEcCtD
Doxorubicin—Epistaxis—Epirubicin—sarcoma	7.26e-06	0.000188	CcSEcCtD
Doxorubicin—Nausea—Thiotepa—sarcoma	7.25e-06	0.000188	CcSEcCtD
Doxorubicin—Sinusitis—Epirubicin—sarcoma	7.22e-06	0.000187	CcSEcCtD
Doxorubicin—Feeling abnormal—Etoposide—sarcoma	7.22e-06	0.000187	CcSEcCtD
Doxorubicin—Diarrhoea—Mitoxantrone—sarcoma	7.21e-06	0.000187	CcSEcCtD
Doxorubicin—Nausea—Dactinomycin—sarcoma	7.19e-06	0.000186	CcSEcCtD
Doxorubicin—Agranulocytosis—Epirubicin—sarcoma	7.19e-06	0.000186	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Etoposide—sarcoma	7.16e-06	0.000185	CcSEcCtD
Doxorubicin—Dizziness—Vincristine—sarcoma	7.15e-06	0.000185	CcSEcCtD
Doxorubicin—Bradycardia—Epirubicin—sarcoma	7.04e-06	0.000182	CcSEcCtD
Doxorubicin—Urticaria—Etoposide—sarcoma	6.96e-06	0.00018	CcSEcCtD
Doxorubicin—Haemoglobin—Epirubicin—sarcoma	6.95e-06	0.00018	CcSEcCtD
Doxorubicin—Rhinitis—Epirubicin—sarcoma	6.93e-06	0.000179	CcSEcCtD
Doxorubicin—Body temperature increased—Etoposide—sarcoma	6.93e-06	0.000179	CcSEcCtD
Doxorubicin—Abdominal pain—Etoposide—sarcoma	6.93e-06	0.000179	CcSEcCtD
Doxorubicin—Haemorrhage—Epirubicin—sarcoma	6.91e-06	0.000179	CcSEcCtD
Doxorubicin—Hepatitis—Epirubicin—sarcoma	6.91e-06	0.000179	CcSEcCtD
Doxorubicin—Hypoaesthesia—Epirubicin—sarcoma	6.88e-06	0.000178	CcSEcCtD
Doxorubicin—Vomiting—Vincristine—sarcoma	6.88e-06	0.000178	CcSEcCtD
Doxorubicin—Pharyngitis—Epirubicin—sarcoma	6.86e-06	0.000178	CcSEcCtD
Doxorubicin—Urinary tract disorder—Epirubicin—sarcoma	6.83e-06	0.000177	CcSEcCtD
Doxorubicin—Rash—Vincristine—sarcoma	6.82e-06	0.000177	CcSEcCtD
Doxorubicin—Dermatitis—Vincristine—sarcoma	6.81e-06	0.000176	CcSEcCtD
Doxorubicin—Oedema peripheral—Epirubicin—sarcoma	6.81e-06	0.000176	CcSEcCtD
Doxorubicin—Connective tissue disorder—Epirubicin—sarcoma	6.79e-06	0.000176	CcSEcCtD
Doxorubicin—Urethral disorder—Epirubicin—sarcoma	6.78e-06	0.000175	CcSEcCtD
Doxorubicin—Headache—Vincristine—sarcoma	6.78e-06	0.000175	CcSEcCtD
Doxorubicin—Vomiting—Mitoxantrone—sarcoma	6.7e-06	0.000173	CcSEcCtD
Doxorubicin—Visual impairment—Epirubicin—sarcoma	6.66e-06	0.000172	CcSEcCtD
Doxorubicin—Rash—Mitoxantrone—sarcoma	6.64e-06	0.000172	CcSEcCtD
Doxorubicin—Dermatitis—Mitoxantrone—sarcoma	6.64e-06	0.000172	CcSEcCtD
Doxorubicin—Headache—Mitoxantrone—sarcoma	6.6e-06	0.000171	CcSEcCtD
Doxorubicin—Erythema multiforme—Epirubicin—sarcoma	6.54e-06	0.000169	CcSEcCtD
Doxorubicin—Eye disorder—Epirubicin—sarcoma	6.46e-06	0.000167	CcSEcCtD
Doxorubicin—Hypersensitivity—Etoposide—sarcoma	6.46e-06	0.000167	CcSEcCtD
Doxorubicin—Tinnitus—Epirubicin—sarcoma	6.45e-06	0.000167	CcSEcCtD
Doxorubicin—Nausea—Vincristine—sarcoma	6.42e-06	0.000166	CcSEcCtD
Doxorubicin—Flushing—Epirubicin—sarcoma	6.42e-06	0.000166	CcSEcCtD
Doxorubicin—Cardiac disorder—Epirubicin—sarcoma	6.42e-06	0.000166	CcSEcCtD
Doxorubicin—Asthenia—Etoposide—sarcoma	6.29e-06	0.000163	CcSEcCtD
Doxorubicin—Angiopathy—Epirubicin—sarcoma	6.27e-06	0.000162	CcSEcCtD
Doxorubicin—Nausea—Mitoxantrone—sarcoma	6.26e-06	0.000162	CcSEcCtD
Doxorubicin—Immune system disorder—Epirubicin—sarcoma	6.24e-06	0.000162	CcSEcCtD
Doxorubicin—Mediastinal disorder—Epirubicin—sarcoma	6.23e-06	0.000161	CcSEcCtD
Doxorubicin—Chills—Epirubicin—sarcoma	6.2e-06	0.000161	CcSEcCtD
Doxorubicin—Pruritus—Etoposide—sarcoma	6.2e-06	0.00016	CcSEcCtD
Doxorubicin—Arrhythmia—Epirubicin—sarcoma	6.18e-06	0.00016	CcSEcCtD
Doxorubicin—Alopecia—Epirubicin—sarcoma	6.11e-06	0.000158	CcSEcCtD
Doxorubicin—ABCB1—lymph node—sarcoma	6.1e-06	0.000347	CbGeAlD
Doxorubicin—Mental disorder—Epirubicin—sarcoma	6.06e-06	0.000157	CcSEcCtD
Doxorubicin—Erythema—Epirubicin—sarcoma	6.02e-06	0.000156	CcSEcCtD
Doxorubicin—Malnutrition—Epirubicin—sarcoma	6.02e-06	0.000156	CcSEcCtD
Doxorubicin—Diarrhoea—Etoposide—sarcoma	6e-06	0.000155	CcSEcCtD
Doxorubicin—Flatulence—Epirubicin—sarcoma	5.93e-06	0.000153	CcSEcCtD
Doxorubicin—Tension—Epirubicin—sarcoma	5.91e-06	0.000153	CcSEcCtD
Doxorubicin—Dysgeusia—Epirubicin—sarcoma	5.89e-06	0.000153	CcSEcCtD
Doxorubicin—Nervousness—Epirubicin—sarcoma	5.85e-06	0.000151	CcSEcCtD
Doxorubicin—Back pain—Epirubicin—sarcoma	5.82e-06	0.000151	CcSEcCtD
Doxorubicin—Dizziness—Etoposide—sarcoma	5.79e-06	0.00015	CcSEcCtD
Doxorubicin—Muscle spasms—Epirubicin—sarcoma	5.79e-06	0.00015	CcSEcCtD
Doxorubicin—Vision blurred—Epirubicin—sarcoma	5.67e-06	0.000147	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	5.62e-06	0.000308	CbGpPWpGaD
Doxorubicin—Ill-defined disorder—Epirubicin—sarcoma	5.58e-06	0.000145	CcSEcCtD
Doxorubicin—Vomiting—Etoposide—sarcoma	5.57e-06	0.000144	CcSEcCtD
Doxorubicin—Anaemia—Epirubicin—sarcoma	5.56e-06	0.000144	CcSEcCtD
Doxorubicin—Agitation—Epirubicin—sarcoma	5.53e-06	0.000143	CcSEcCtD
Doxorubicin—Rash—Etoposide—sarcoma	5.52e-06	0.000143	CcSEcCtD
Doxorubicin—Dermatitis—Etoposide—sarcoma	5.52e-06	0.000143	CcSEcCtD
Doxorubicin—NOS2—Disease—PLCG1—sarcoma	5.5e-06	0.000302	CbGpPWpGaD
Doxorubicin—Headache—Etoposide—sarcoma	5.49e-06	0.000142	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	5.47e-06	0.0003	CbGpPWpGaD
Doxorubicin—Malaise—Epirubicin—sarcoma	5.43e-06	0.00014	CcSEcCtD
Doxorubicin—Vertigo—Epirubicin—sarcoma	5.41e-06	0.00014	CcSEcCtD
Doxorubicin—Syncope—Epirubicin—sarcoma	5.4e-06	0.00014	CcSEcCtD
Doxorubicin—Leukopenia—Epirubicin—sarcoma	5.39e-06	0.000139	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—TLE1—sarcoma	5.34e-06	0.000293	CbGpPWpGaD
Doxorubicin—Palpitations—Epirubicin—sarcoma	5.32e-06	0.000138	CcSEcCtD
Doxorubicin—Loss of consciousness—Epirubicin—sarcoma	5.29e-06	0.000137	CcSEcCtD
Doxorubicin—NOS2—Disease—CXCR4—sarcoma	5.28e-06	0.00029	CbGpPWpGaD
Doxorubicin—Cough—Epirubicin—sarcoma	5.25e-06	0.000136	CcSEcCtD
Doxorubicin—Convulsion—Epirubicin—sarcoma	5.21e-06	0.000135	CcSEcCtD
Doxorubicin—Nausea—Etoposide—sarcoma	5.2e-06	0.000135	CcSEcCtD
Doxorubicin—Hypertension—Epirubicin—sarcoma	5.2e-06	0.000134	CcSEcCtD
Doxorubicin—NOS1—Disease—FOXO1—sarcoma	5.17e-06	0.000284	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ENO2—sarcoma	5.17e-06	0.000284	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PDGFRB—sarcoma	5.16e-06	0.000283	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—HBA1—sarcoma	5.14e-06	0.000282	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—CCND1—sarcoma	5.13e-06	0.000281	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—HRAS—sarcoma	5.12e-06	0.000281	CbGpPWpGaD
Doxorubicin—Myalgia—Epirubicin—sarcoma	5.12e-06	0.000133	CcSEcCtD
Doxorubicin—Chest pain—Epirubicin—sarcoma	5.12e-06	0.000133	CcSEcCtD
Doxorubicin—Arthralgia—Epirubicin—sarcoma	5.12e-06	0.000133	CcSEcCtD
Doxorubicin—Anxiety—Epirubicin—sarcoma	5.11e-06	0.000132	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	5.09e-06	0.000132	CcSEcCtD
Doxorubicin—NOS1—Disease—PDGFRA—sarcoma	5.08e-06	0.000279	CbGpPWpGaD
Doxorubicin—Discomfort—Epirubicin—sarcoma	5.06e-06	0.000131	CcSEcCtD
Doxorubicin—AKR1C3—Disease—PLCG1—sarcoma	5.05e-06	0.000277	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	5.03e-06	0.000276	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ENO2—sarcoma	5.03e-06	0.000276	CbGpPWpGaD
Doxorubicin—Dry mouth—Epirubicin—sarcoma	5.01e-06	0.00013	CcSEcCtD
Doxorubicin—NOS1—Hemostasis—SRC—sarcoma	5e-06	0.000274	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ENO2—sarcoma	4.99e-06	0.000274	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—HBA1—sarcoma	4.95e-06	0.000272	CbGpPWpGaD
Doxorubicin—Confusional state—Epirubicin—sarcoma	4.95e-06	0.000128	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	4.92e-06	0.00027	CbGpPWpGaD
Doxorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	4.92e-06	0.00027	CbGpPWpGaD
Doxorubicin—Oedema—Epirubicin—sarcoma	4.91e-06	0.000127	CcSEcCtD
Doxorubicin—Anaphylactic shock—Epirubicin—sarcoma	4.91e-06	0.000127	CcSEcCtD
Doxorubicin—Infection—Epirubicin—sarcoma	4.88e-06	0.000126	CcSEcCtD
Doxorubicin—NOS1—Hemostasis—VEGFA—sarcoma	4.87e-06	0.000267	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CXCR4—sarcoma	4.85e-06	0.000266	CbGpPWpGaD
Doxorubicin—Shock—Epirubicin—sarcoma	4.83e-06	0.000125	CcSEcCtD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	4.83e-06	0.000265	CbGpPWpGaD
Doxorubicin—Nervous system disorder—Epirubicin—sarcoma	4.82e-06	0.000125	CcSEcCtD
Doxorubicin—Thrombocytopenia—Epirubicin—sarcoma	4.81e-06	0.000124	CcSEcCtD
Doxorubicin—NOS1—Hemostasis—NRAS—sarcoma	4.81e-06	0.000264	CbGpPWpGaD
Doxorubicin—Tachycardia—Epirubicin—sarcoma	4.79e-06	0.000124	CcSEcCtD
Doxorubicin—Skin disorder—Epirubicin—sarcoma	4.77e-06	0.000123	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—IGF1R—sarcoma	4.76e-06	0.000261	CbGpPWpGaD
Doxorubicin—Hyperhidrosis—Epirubicin—sarcoma	4.75e-06	0.000123	CcSEcCtD
Doxorubicin—Anorexia—Epirubicin—sarcoma	4.68e-06	0.000121	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.65e-06	0.000255	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ENO2—sarcoma	4.64e-06	0.000254	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—HBA1—sarcoma	4.61e-06	0.000253	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle, Mitotic—MYC—sarcoma	4.6e-06	0.000252	CbGpPWpGaD
Doxorubicin—Hypotension—Epirubicin—sarcoma	4.59e-06	0.000119	CcSEcCtD
Doxorubicin—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	4.57e-06	0.000251	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—FOXO1—sarcoma	4.53e-06	0.000249	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PDGFRB—sarcoma	4.52e-06	0.000248	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TLE1—sarcoma	4.51e-06	0.000248	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFC—sarcoma	4.5e-06	0.000247	CbGpPWpGaD
Doxorubicin—Musculoskeletal discomfort—Epirubicin—sarcoma	4.47e-06	0.000116	CcSEcCtD
Doxorubicin—YWHAG—Cell Cycle—MDM2—sarcoma	4.46e-06	0.000245	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PDGFRA—sarcoma	4.45e-06	0.000244	CbGpPWpGaD
Doxorubicin—Insomnia—Epirubicin—sarcoma	4.44e-06	0.000115	CcSEcCtD
Doxorubicin—Paraesthesia—Epirubicin—sarcoma	4.41e-06	0.000114	CcSEcCtD
Doxorubicin—NQO1—Metabolism—PLCG1—sarcoma	4.38e-06	0.000241	CbGpPWpGaD
Doxorubicin—Dyspnoea—Epirubicin—sarcoma	4.38e-06	0.000113	CcSEcCtD
Doxorubicin—Somnolence—Epirubicin—sarcoma	4.37e-06	0.000113	CcSEcCtD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—CCND1—sarcoma	4.34e-06	0.000239	CbGpPWpGaD
Doxorubicin—Dyspepsia—Epirubicin—sarcoma	4.32e-06	0.000112	CcSEcCtD
Doxorubicin—NOS2—Hemostasis—IL2—sarcoma	4.32e-06	0.000237	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL2—sarcoma	4.3e-06	0.000236	CbGpPWpGaD
Doxorubicin—Decreased appetite—Epirubicin—sarcoma	4.27e-06	0.000111	CcSEcCtD
Doxorubicin—NOS3—Disease—PLCG1—sarcoma	4.27e-06	0.000234	CbGpPWpGaD
Doxorubicin—Gastrointestinal disorder—Epirubicin—sarcoma	4.24e-06	0.00011	CcSEcCtD
Doxorubicin—Fatigue—Epirubicin—sarcoma	4.23e-06	0.00011	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism—PLCG1—sarcoma	4.23e-06	0.000232	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	4.22e-06	0.000231	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ENO2—sarcoma	4.21e-06	0.000231	CbGpPWpGaD
Doxorubicin—Pain—Epirubicin—sarcoma	4.2e-06	0.000109	CcSEcCtD
Doxorubicin—Constipation—Epirubicin—sarcoma	4.2e-06	0.000109	CcSEcCtD
Doxorubicin—NOS3—Metabolism—HBA1—sarcoma	4.19e-06	0.00023	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—KRAS—sarcoma	4.14e-06	0.000227	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	4.13e-06	0.000227	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—MYC—sarcoma	4.11e-06	0.000226	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CXCR4—sarcoma	4.1e-06	0.000225	CbGpPWpGaD
Doxorubicin—Feeling abnormal—Epirubicin—sarcoma	4.05e-06	0.000105	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Epirubicin—sarcoma	4.02e-06	0.000104	CcSEcCtD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—sarcoma	3.97e-06	0.000218	CbGpPWpGaD
Doxorubicin—NOS1—Disease—KIT—sarcoma	3.94e-06	0.000216	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PLCG1—sarcoma	3.93e-06	0.000216	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TLE1—sarcoma	3.92e-06	0.000215	CbGpPWpGaD
Doxorubicin—Urticaria—Epirubicin—sarcoma	3.9e-06	0.000101	CcSEcCtD
Doxorubicin—NOS2—Disease—FOXO1—sarcoma	3.9e-06	0.000214	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PDGFRB—sarcoma	3.89e-06	0.000214	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	3.89e-06	0.000213	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CCND1—sarcoma	3.88e-06	0.000213	CbGpPWpGaD
Doxorubicin—Body temperature increased—Epirubicin—sarcoma	3.88e-06	0.0001	CcSEcCtD
Doxorubicin—Abdominal pain—Epirubicin—sarcoma	3.88e-06	0.0001	CcSEcCtD
Doxorubicin—NOS2—Disease—PDGFRA—sarcoma	3.83e-06	0.00021	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFC—sarcoma	3.8e-06	0.000209	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—SRC—sarcoma	3.77e-06	0.000207	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CREB1—sarcoma	3.75e-06	0.000206	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—KDR—sarcoma	3.75e-06	0.000206	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—sarcoma	3.68e-06	0.000202	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—VEGFA—sarcoma	3.67e-06	0.000202	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—VEGFA—sarcoma	3.65e-06	0.0002	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—NRAS—sarcoma	3.63e-06	0.000199	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Epirubicin—sarcoma	3.62e-06	9.37e-05	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—FLT1—sarcoma	3.6e-06	0.000198	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—FOXO1—sarcoma	3.58e-06	0.000197	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PDGFRB—sarcoma	3.58e-06	0.000196	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PLCG1—sarcoma	3.57e-06	0.000196	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NPM1—sarcoma	3.54e-06	0.000194	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PLCG1—sarcoma	3.54e-06	0.000194	CbGpPWpGaD
Doxorubicin—Asthenia—Epirubicin—sarcoma	3.52e-06	9.12e-05	CcSEcCtD
Doxorubicin—AKR1C3—Disease—PDGFRA—sarcoma	3.52e-06	0.000193	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—HRAS—sarcoma	3.52e-06	0.000193	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—MYC—sarcoma	3.48e-06	0.000191	CbGpPWpGaD
Doxorubicin—Pruritus—Epirubicin—sarcoma	3.47e-06	8.99e-05	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—KIT—sarcoma	3.45e-06	0.000189	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ENO2—sarcoma	3.42e-06	0.000188	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCR4—sarcoma	3.4e-06	0.000187	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—HBA1—sarcoma	3.4e-06	0.000186	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—sarcoma	3.38e-06	0.000185	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ATF1—sarcoma	3.36e-06	0.000185	CbGpPWpGaD
Doxorubicin—Diarrhoea—Epirubicin—sarcoma	3.36e-06	8.7e-05	CcSEcCtD
Doxorubicin—NOS3—Hemostasis—IL2—sarcoma	3.35e-06	0.000184	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CREB1—sarcoma	3.29e-06	0.00018	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ENO2—sarcoma	3.28e-06	0.00018	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—HBA1—sarcoma	3.26e-06	0.000179	CbGpPWpGaD
Doxorubicin—Dizziness—Epirubicin—sarcoma	3.25e-06	8.41e-05	CcSEcCtD
Doxorubicin—Vomiting—Epirubicin—sarcoma	3.12e-06	8.08e-05	CcSEcCtD
Doxorubicin—NOS2—Hemostasis—KRAS—sarcoma	3.12e-06	0.000171	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MDM2—sarcoma	3.12e-06	0.000171	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—MYC—sarcoma	3.12e-06	0.000171	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MDM2—sarcoma	3.1e-06	0.00017	CbGpPWpGaD
Doxorubicin—Rash—Epirubicin—sarcoma	3.1e-06	8.02e-05	CcSEcCtD
Doxorubicin—Dermatitis—Epirubicin—sarcoma	3.09e-06	8.01e-05	CcSEcCtD
Doxorubicin—Headache—Epirubicin—sarcoma	3.08e-06	7.96e-05	CcSEcCtD
Doxorubicin—ABCC1—Disease—ENO2—sarcoma	3.07e-06	0.000168	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FLT1—sarcoma	3.04e-06	0.000167	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—sarcoma	3.04e-06	0.000167	CbGpPWpGaD
Doxorubicin—NOS3—Disease—FOXO1—sarcoma	3.03e-06	0.000166	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PDGFRB—sarcoma	3.02e-06	0.000166	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PLCG1—sarcoma	2.99e-06	0.000164	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PDGFRA—sarcoma	2.98e-06	0.000163	CbGpPWpGaD
Doxorubicin—NOS2—Disease—KIT—sarcoma	2.97e-06	0.000163	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—SRC—sarcoma	2.93e-06	0.000161	CbGpPWpGaD
Doxorubicin—Nausea—Epirubicin—sarcoma	2.92e-06	7.55e-05	CcSEcCtD
Doxorubicin—ABCB11—Metabolism—PLCG1—sarcoma	2.9e-06	0.000159	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCR4—sarcoma	2.87e-06	0.000158	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.87e-06	0.000157	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—VEGFA—sarcoma	2.85e-06	0.000157	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ATF1—sarcoma	2.84e-06	0.000156	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CREB1—sarcoma	2.83e-06	0.000155	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—NRAS—sarcoma	2.82e-06	0.000155	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PLCG1—sarcoma	2.78e-06	0.000153	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—sarcoma	2.77e-06	0.000152	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—KIT—sarcoma	2.73e-06	0.00015	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MDM2—sarcoma	2.72e-06	0.000149	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CCND1—sarcoma	2.72e-06	0.000149	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CTNNB1—sarcoma	2.68e-06	0.000147	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HRAS—sarcoma	2.65e-06	0.000146	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IGF1R—sarcoma	2.64e-06	0.000145	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PLCG1—sarcoma	2.6e-06	0.000143	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CREB1—sarcoma	2.6e-06	0.000143	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ENO2—sarcoma	2.57e-06	0.000141	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—sarcoma	2.56e-06	0.00014	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—HBA1—sarcoma	2.55e-06	0.00014	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FOXO1—sarcoma	2.51e-06	0.000138	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PDGFRB—sarcoma	2.51e-06	0.000138	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CXCR4—sarcoma	2.5e-06	0.000137	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ENO2—sarcoma	2.48e-06	0.000136	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—HBA1—sarcoma	2.47e-06	0.000135	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PDGFRA—sarcoma	2.47e-06	0.000135	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—MYC—sarcoma	2.44e-06	0.000134	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2—sarcoma	2.43e-06	0.000133	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—KRAS—sarcoma	2.42e-06	0.000133	CbGpPWpGaD
Doxorubicin—NOS1—Disease—SRC—sarcoma	2.42e-06	0.000133	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.37e-06	0.00013	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCND1—sarcoma	2.37e-06	0.00013	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—JUN—sarcoma	2.36e-06	0.00013	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CTNNB1—sarcoma	2.34e-06	0.000129	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MDM2—sarcoma	2.34e-06	0.000129	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NRAS—sarcoma	2.33e-06	0.000128	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KIT—sarcoma	2.31e-06	0.000127	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ENO2—sarcoma	2.26e-06	0.000124	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—HBA1—sarcoma	2.24e-06	0.000123	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF1R—sarcoma	2.23e-06	0.000122	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CREB1—sarcoma	2.2e-06	0.000121	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MYC—sarcoma	2.18e-06	0.00012	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PLCG1—sarcoma	2.18e-06	0.00012	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MYC—sarcoma	2.17e-06	0.000119	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—sarcoma	2.15e-06	0.000118	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MDM2—sarcoma	2.15e-06	0.000118	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FOXO1—sarcoma	2.12e-06	0.000116	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EGFR—sarcoma	2.12e-06	0.000116	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SRC—sarcoma	2.12e-06	0.000116	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PDGFRB—sarcoma	2.12e-06	0.000116	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PLCG1—sarcoma	2.11e-06	0.000116	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PDGFRA—sarcoma	2.08e-06	0.000114	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KDR—sarcoma	2.08e-06	0.000114	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.07e-06	0.000113	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—VEGFA—sarcoma	2.06e-06	0.000113	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.06e-06	0.000113	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HRAS—sarcoma	2.06e-06	0.000113	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2.05e-06	0.000112	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NRAS—sarcoma	2.04e-06	0.000112	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CTNNB1—sarcoma	2.02e-06	0.000111	CbGpPWpGaD
Doxorubicin—NOS1—Disease—KRAS—sarcoma	2e-06	0.00011	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PLCG1—sarcoma	1.92e-06	0.000105	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KIT—sarcoma	1.91e-06	0.000105	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MYC—sarcoma	1.9e-06	0.000104	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EGFR—sarcoma	1.86e-06	0.000102	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CTNNB1—sarcoma	1.86e-06	0.000102	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.85e-06	0.000102	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FOXO1—sarcoma	1.85e-06	0.000101	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PDGFRB—sarcoma	1.84e-06	0.000101	CbGpPWpGaD
Doxorubicin—NOS2—Disease—SRC—sarcoma	1.82e-06	0.0001	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CREB1—sarcoma	1.82e-06	0.0001	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MDM2—sarcoma	1.82e-06	9.98e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PDGFRA—sarcoma	1.81e-06	9.96e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.8e-06	9.89e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—sarcoma	1.79e-06	9.83e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NRAS—sarcoma	1.76e-06	9.64e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—KRAS—sarcoma	1.75e-06	9.63e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KDR—sarcoma	1.75e-06	9.63e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HRAS—sarcoma	1.7e-06	9.35e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—SRC—sarcoma	1.68e-06	9.21e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.66e-06	9.1e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ENO2—sarcoma	1.66e-06	9.09e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HBA1—sarcoma	1.65e-06	9.03e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MYC—sarcoma	1.64e-06	8.98e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.62e-06	8.9e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KIT—sarcoma	1.62e-06	8.87e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NRAS—sarcoma	1.61e-06	8.86e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EGFR—sarcoma	1.6e-06	8.78e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CTNNB1—sarcoma	1.57e-06	8.61e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—sarcoma	1.56e-06	8.56e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CREB1—sarcoma	1.54e-06	8.45e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.53e-06	8.41e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—KRAS—sarcoma	1.51e-06	8.3e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MDM2—sarcoma	1.51e-06	8.27e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MYC—sarcoma	1.5e-06	8.25e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRAS—sarcoma	1.49e-06	8.19e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EGFR—sarcoma	1.47e-06	8.07e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—SRC—sarcoma	1.42e-06	7.78e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KIT—sarcoma	1.41e-06	7.72e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PLCG1—sarcoma	1.4e-06	7.71e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—KRAS—sarcoma	1.39e-06	7.62e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NRAS—sarcoma	1.36e-06	7.48e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.36e-06	7.47e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—sarcoma	1.35e-06	7.39e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CREB1—sarcoma	1.34e-06	7.35e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCND1—sarcoma	1.31e-06	7.2e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—JUN—sarcoma	1.31e-06	7.19e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CTNNB1—sarcoma	1.3e-06	7.13e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HRAS—sarcoma	1.28e-06	7.05e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MDM2—sarcoma	1.27e-06	6.99e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MYC—sarcoma	1.27e-06	6.97e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EGFR—sarcoma	1.24e-06	6.82e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ENO2—sarcoma	1.22e-06	6.71e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HBA1—sarcoma	1.21e-06	6.66e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—sarcoma	1.18e-06	6.48e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SRC—sarcoma	1.17e-06	6.45e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KRAS—sarcoma	1.17e-06	6.44e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ENO2—sarcoma	1.15e-06	6.32e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—sarcoma	1.14e-06	6.28e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HBA1—sarcoma	1.14e-06	6.28e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—sarcoma	1.14e-06	6.24e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NRAS—sarcoma	1.13e-06	6.2e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCND1—sarcoma	1.11e-06	6.09e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MDM2—sarcoma	1.11e-06	6.08e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JUN—sarcoma	1.11e-06	6.07e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CTNNB1—sarcoma	1.1e-06	6.03e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—sarcoma	1.05e-06	5.78e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLCG1—sarcoma	1.04e-06	5.69e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—sarcoma	1.03e-06	5.65e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—sarcoma	9.97e-07	5.48e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SRC—sarcoma	9.92e-07	5.45e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLCG1—sarcoma	9.77e-07	5.36e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KRAS—sarcoma	9.72e-07	5.34e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—sarcoma	9.66e-07	5.31e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CTNNB1—sarcoma	9.55e-07	5.24e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NRAS—sarcoma	9.55e-07	5.24e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—sarcoma	8.89e-07	4.88e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—sarcoma	8.7e-07	4.78e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—sarcoma	8.64e-07	4.75e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SRC—sarcoma	8.63e-07	4.74e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NRAS—sarcoma	8.31e-07	4.56e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—sarcoma	8.27e-07	4.54e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KRAS—sarcoma	8.22e-07	4.51e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—sarcoma	7.74e-07	4.25e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—sarcoma	7.57e-07	4.16e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ENO2—sarcoma	7.52e-07	4.13e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HBA1—sarcoma	7.48e-07	4.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—sarcoma	7.3e-07	4.01e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KRAS—sarcoma	7.15e-07	3.93e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—sarcoma	6.98e-07	3.83e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLCG1—sarcoma	6.38e-07	3.51e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—sarcoma	6.08e-07	3.34e-05	CbGpPWpGaD
